drugset / Trial / NCT05741437

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378

NCT05741437

Phase 1 Completed 24 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A clinical trial to compare and evaluate the safety and pharmacokinetics of CKD-378

Timeline

Start
2023-04-11
Primary completion
2023-08-31
Completion
2023-09-05

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-378 Unknown Oral
Subject D150 Unknown Oral
Subject D745 Unknown Oral